University of Alberta researchers have discovered a new method to identify the severity of Lou Gehrig’s disease in patients and track its progression.
The U of A team, led by Sanjay Kalra, a professor in the Division of Neurology, has made progress toward an imaging biomarker for white-matter degeneration in the brains of ALS patients, which they hope will lead to earlier diagnosis and potential new therapeutics.
